Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: ACC's statement on $1.9T relief bill | A 'critical sign of ill health' | How to maintain certification

News You Need to Know Today
Week in Review: ACC's statement on $1.9T relief bill | A 'critical sign of ill health' | How to maintain certification
Saturday, March 13, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Several countries pause use of AstraZeneca COVID-19 vaccine due to blood clot concerns—US still sitting on millions of doses

While countries around the world have shared concerns, the World Health Organization and European Medicines Agency both still support the use of the vaccine. 

READ MORE >
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
Share on Twitter Share on Facebook Share on Linkedin

Several countries pause use of AstraZeneca COVID-19 vaccine due to blood clot concerns—US still sitting on millions of doses

Share on Twitter Share on Facebook Share on Linkedin
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.
While countries around the world have shared concerns, the World Health Organization and European Medicines Agency both still support the use of the vaccine. 
READ MORE >

American College of Cardiology: Biden’s $1.9T COVID-19 relief bill will help reduce healthcare disparities

Biden signed the legislation Thursday, March 11, one day earlier than expected. 

READ MORE >
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology: Biden’s $1.9T COVID-19 relief bill will help reduce healthcare disparities

Share on Twitter Share on Facebook Share on Linkedin
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Biden signed the legislation Thursday, March 11, one day earlier than expected. 
READ MORE >

‘A cardiovascular problem disguised as an eye problem’: Why CRAO requires immediate treatment

These strokes are a "critical sign of ill health" and are often followed by other serious vascular issues, a group of specialists warned. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

‘A cardiovascular problem disguised as an eye problem’: Why CRAO requires immediate treatment

Share on Twitter Share on Facebook Share on Linkedin
These strokes are a "critical sign of ill health" and are often followed by other serious vascular issues, a group of specialists warned. 
READ MORE >

New Jersey cardiologist faces up to 20 years in prison for illegally distributing Oxycodone

The 59-year-old cardiologist prescribed and distributed more than 8,000 Oxycodone pills. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

New Jersey cardiologist faces up to 20 years in prison for illegally distributing Oxycodone

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The 59-year-old cardiologist prescribed and distributed more than 8,000 Oxycodone pills. 
READ MORE >

Plant-based diets associated with a lower risk of stroke—but not if they are full of junk food

Eating a healthy plant-based diet—meaning a diet high in plant-based foods, not necessarily one that is exclusively plant-based—has been linked with lowering a person’s overall stroke risk by up to 10%.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Plant-based diets associated with a lower risk of stroke—but not if they are full of junk food

Share on Twitter Share on Facebook Share on Linkedin
Eating a healthy plant-based diet—meaning a diet high in plant-based foods, not necessarily one that is exclusively plant-based—has been linked with lowering a person’s overall stroke risk by up to 10%.
READ MORE >

5 important tips about COVID-19 vaccines for heart failure, heart transplant patients

As more and more Americans receive their COVID-19 vaccine, heart failure patients and heart transplant recipients may have specific questions about how they should proceed.

READ MORE >
Covid Vaccine
Share on Twitter Share on Facebook Share on Linkedin

5 important tips about COVID-19 vaccines for heart failure, heart transplant patients

Share on Twitter Share on Facebook Share on Linkedin
Covid Vaccine
As more and more Americans receive their COVID-19 vaccine, heart failure patients and heart transplant recipients may have specific questions about how they should proceed.
READ MORE >

How heart rhythm issues affect 2-year TAVR, SAVR outcomes

The study’s authors explored data from more than 900 low-risk patients who participated in the PARTNER 3 trial.

READ MORE >
patient with heart doctor
Share on Twitter Share on Facebook Share on Linkedin

How heart rhythm issues affect 2-year TAVR, SAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
patient with heart doctor
The study’s authors explored data from more than 900 low-risk patients who participated in the PARTNER 3 trial.
READ MORE >

Wearable ECG devices detect AFib among older patients, reducing the risk of stroke

The new study, published in JAMA Cardiology, included more than 800 hypertension patients aged 75 years or older. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Wearable ECG devices detect AFib among older patients, reducing the risk of stroke

Share on Twitter Share on Facebook Share on Linkedin
The new study, published in JAMA Cardiology, included more than 800 hypertension patients aged 75 years or older. 
READ MORE >

What cardiologists need to know about maintaining certification

Becoming board certified is a massive moment in any physician’s career, one that represents years and years of hard work and dedication.

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

What cardiologists need to know about maintaining certification

Share on Twitter Share on Facebook Share on Linkedin
women doctors
Becoming board certified is a massive moment in any physician’s career, one that represents years and years of hard work and dedication.
READ MORE >

Beta-blockers, ACE inhibitors, ARBs lead to improved long-term outcomes for aortic dissection patients

The study's authors tracked nearly 7,000 adult AD patients who were treated from 2001 to 2013.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Beta-blockers, ACE inhibitors, ARBs lead to improved long-term outcomes for aortic dissection patients

Share on Twitter Share on Facebook Share on Linkedin
The study's authors tracked nearly 7,000 adult AD patients who were treated from 2001 to 2013.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

FDA warns public after patient death | Medtronic recalls heart devices | 'Compelling' new PE data | Pushing for TAVR changes
News Alert: Medtronic recalls thousands of surgical devices
New IVL tech overcomes previous limitations | 3-year SMART data looks at TAVR outcomes | Artivion acquires Endospan for $135M
FDA approves next-gen mitral valve | Doctors are first in world to use new TAVR technique | Preventing a common complication
Key updates in PFA & beyond | More good IVL news for Boston Scientific | FDA approves new hypertension drug
Cardiologists scramble to prepare for new policy | Boston Scientific invests $1.5B in TAVR developer | FDA clears cath lab tech
The latest on PFA risks | EP catheters recalled | Doctors exempt from work visa freeze | Good news for Heartflow

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Current page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme